PD-L1-IN-5 (X22) is an orally active PD-L1 inhibitor, with the IC 50 value of 785.6 nM. PD-L1-IN-5 has anti-tumor activity in vivo .
Products | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Signaling Pathways > PD-1/PD-L1
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.